[The Business Times] Revolutionising drug discovery with AI in South-east Asia
NYB AI, NYB's subsidiary, is featured in The Business Times for transforming drug discovery in Southeast Asia with its AI platform, DTIGN.
The article highlights how DTIGN leverages advanced graph neural networks and molecular docking to accelerate and improve the accuracy of drug-target predictions, focusing on both pharmaceutical and plant-based compounds.
NYB AI’s partnerships with leading tech companies and recognition from industry leaders underscore its impact on making drug discovery faster, more affordable, and sustainable.
.jpeg)